DSM to strengthen her position

DSM, the global Life Sciences and Materials Sciences company, and Martek Biosciences Corporation announced that DSM will acquire 100% of the shares of Martek.

The acquisition adds new growth platform for natural, healthy Polyunsaturated Fatty Acids (PUFAs) nutrition ingredients (Omega-3 DHA and Omega-6 ARA). PUFAs are clinically proven to have important human health benefits. Martek is a leader in this field with strong positions, especially in Infant Formula Nutrition applications. This acquisition positions DSM as a leader in PUFAs and in Infant Nutrition, greatly strengthens DSM's presence in the United States and expands DSM's complementary technology platform in the field of algal and other microbial fermentations.